Managing Editor's Note: Below is a letter sent to Dr. Marshalyn Yeargin- Alsopp, Medical Epidemiologist and Chief of the Developmental Disabilities Branch of the CDC. We'll let you know if Louise Kuo Habakus (in photo), co-editor of Vaccine Epidemic and Executive Director for FocusAutismInc., receives a response.
Marshalyn Yeargin-Alsopp, MD
Chief, Developmental Disabilities Branch, NCBDDD
Centers for Disease Control and Prevention
1600 Clifton Road
Atlanta, GA 30333
Re: Congressional briefing on new autism statistics – April 25, 2012
Dear Dr. Yeargin-Alsopp,
I was glad for the opportunity to meet you at the congressional briefing sponsored by Autism Speaks on April 25 in Rayburn. My boss, Barry Segal, was on an extended trip in the Far East and I wanted to update him before sending this letter.
Thank you for your presentation about the new autism prevalence statistics.
During the Question & Answer period, you called on me. I said that I come from New Jersey, where autism affects a shocking 1 in 29 boys. In your Study to Explore Early Development (SEED), you will not be studying toxins. I expressed deep concern that the CDC is not investigating vaccines as a possible link to skyrocketing autism rates, especially in view of peer-reviewed science that raises grave concerns, and numerous parental reports of autism diagnosis following their children’s post-vaccinal regression.
After the meeting ended, I introduced myself to you and you were kind enough to address my question. You explained that you had neither the marching orders nor the funding to pursue a vaccine causation hypothesis. You said that you were sorely in need of additional funding and suggested that I contact your boss to make this recommendation.
As you suggested, I am copying Dr. Frieden. Barry and I are eager for his and your reply.
My best wishes,
Louise Kuo Habakus
C: Thomas Frieden, MD, MPH
Barry Segal, Founder, Focus Autism